My focus is on the pathology and natural history of prostate, testicular and penile cancer working to translate basic research into practical treatments for patients with novel tests and bespoke predictive treatments.
Professor Berney is an internationally recognised pathology expert in the three male GU cancers. He works at the Royal London Hospital and receives referrals nationally and internationally for his opinion. He is co Editor of the next WHO classification of GU cancers, and has published over 270 papers, with an H score of 71 and over 20,000 citations. He is editor in Chief of ‘Histopathology’, the leading general pathology journal in Europe.
He has helped to pioneer changes in the grading of prostate cancer, and two new tests to work out disease aggressiveness. In testis cancer he is helping refine decisions on adjuvant chemotherapy and treatment in early disease and has helped identify cases which are now known to be benign but were previously thought to be malignant.
He is now working on refining treatment and oncological decisions in advanced prostate cancer, working with Pressor Attard at UCL, using the 10,000 strong STAMPEDE trial and with a Danish group on the treatment of testicular cancer.